Influence of Consecutive‐Day Blood Sampling on Polymerase Chain Reaction–Adjusted Parasitological Cure Rates in an Antimalarial‐Drug Trial Conducted in Tanzania
1Infectious Diseases Unit, Department of Medicine, and 2Clinical Epidemiology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, 3Emergency Medicine Unit, Department of Medicine, Kullbergska Hospital, Katrineholm, and 4Clinical Research Centre, Örebro University Hospital, Örebro, Sweden; 5Department of Parasitology, Muhimbili Univerity College of Health Sciences, Dar es Salaam, Tanzania; 6Centre of Molecular and Structural Biomedicine, University of Algarve, Faro, Portugal
We assessed the influence that consecutive‐day blood sampling, compared with single‐day blood sampling, had on polymerase chain reaction (PCR)–adjusted parasitological cure after stepwise genotyping of merozoite surface proteins 2 (msp2) and 1 (msp1) in 106 children in Tanzania who had uncomplicated falciparum malaria treated with either sulfadoxine‐pyrimethamine or artemether‐lumefantrine; 78 of these children developed recurrent parasitemia during the 42‐day follow‐up period. Initial msp2 genotyping identified 27 and 33 recrudescences by use of single‐ and consecutive‐day sampling, respectively; in subsequent msp1 genotyping, 17 and 21 of these episodes, respectively, were still classified as recrudescences; these results indicate a similar sensitivity of the standard single‐day PCR protocol—that is, 82% (27/33) and 81% (17/21), in both genotyping steps. Interpretation of PCR‐adjusted results will significantly depend on methodology.
Received 21 March 2006; accepted 2 October 2006; electronically published 5 January 2007.
Cited by
Online publication date: 15-Nov-2008.
-
Potential conflicts of interest: none reported.
Financial support: Swedish Development Cooperation Agency–Department for Research Cooperation (grants SWE 2005‐017 and SWE 2005‐004596); Research and Development Unit, Sörmland Count Council, Sweden (project grant 82090); Goljes Foundation (project grants 248/04 and 317/05).





